Healthcare Services

Hidradenitis Suppurativa Market Forecast 2026–2035 Reflecting Expansion Opportunities Across Industries

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Expansion Is Predicted For The Hidradenitis Suppurativa Market Between 2026 And 2030?

The hidradenitis suppurativa market has shown substantial growth in recent years. It is anticipated to increase from $1.24 billion in 2025 to $1.33 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 6.8%. The historical expansion of this market can be linked to factors such as the rising incidence of chronic inflammatory skin disorders, enhanced diagnostic abilities in dermatology, increased public understanding of HS symptoms, the expansion of dermatology clinics, and the presence of antibiotic treatment options.

The hidradenitis suppurativa market is projected to experience substantial expansion over the next few years. By 2030, its value is anticipated to reach $1.75 billion, achieving a compound annual growth rate (CAGR) of 7.0%. This growth during the forecast period is propelled by several factors, including the increasing demand for targeted biologic drugs, a heightened focus on long-term disease management, the broadening scope of personalized dermatology care, the rising adoption of advanced laser therapies, and increasing investment in chronic skin disease research. Key trends anticipated in this period encompass the growing integration of biologic therapies for hs, the rising application of minimally invasive surgical treatments, a stronger emphasis on early disease diagnosis, the expansion of combination treatment approaches, and enhanced patient-centric care models.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12599&type=smp

What Major Drivers Are Influencing Demand In The Hidradenitis Suppurativa Market?

The increasing occurrence of skin conditions is propelling the expansion of the hidradenitis suppurativa market in the future. Skin ailments encompass a diverse array of dermatological issues, such as those caused by bacterial, viral, or fungal infections, allergic reactions, skin cancers, and parasitic infestations. Hidradenitis suppurativa (HS), a chronic and severe dermatological condition, is stimulating the creation of novel products and services for its treatment, thanks to enhanced awareness, precise diagnosis, an expanding patient population, and progress in research. For example, in January 2024, the American Cancer Society, a US-based non-profit organization focused on eradicating cancer, projected 108,270 documented instances of skin cancer, which represents a 3.2% rise from the 104,930 cases recorded in 2023. Consequently, the growing incidence of skin disorders fuels the expansion of the hidradenitis suppurativa market.

Which Market Segments Are Examined In The Hidradenitis Suppurativa Market Study?

The hidradenitis suppurativa market covered in this report is segmented –

1) By Disease Severity: Hurley Stage I, Hurley Stage II, Hurley Stage III

2) By Treatment: Medications, Surgical Treatment

3) By Route of Administration: Oral, Subcutaneous, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies

5) By End User: Hospitals, Dermatology Clinics Or Specialty Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Medications: Antibiotics, Biologics, Hormonal Therapy, Immunosuppressants, Retinoids

2) By Surgical Treatment: Incision and Drainage, Deroofing, Wide Excision, Laser & Light-Based Therapy

Which Trends Are Influencing The Hidradenitis Suppurativa Market?

Major companies in the hidradenitis suppurativa market are focusing on developing advanced biologic therapies to improve treatment outcomes and address unmet medical needs. These biologics are medications derived from living organisms that target specific components of the immune system involved in disease progression. For instance, in June 2023, Novartis AG, a Switzerland-based pharmaceutical company, received European regulatory approval for Cosentyx for hidradenitis suppurativa. Cosentyx is the first and only fully human biologic that specifically inhibits interleukin-17A, a key cytokine implicated in hidradenitis suppurativa. With over 14 years of clinical research, Cosentyx provides a well-established and targeted therapeutic option, reinforcing Novartis’s position in the hidradenitis suppurativa market.

Who Are The Primary Competitors In The Hidradenitis Suppurativa Market?

Major companies operating in the hidradenitis suppurativa market are AbbVie Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Eli Lilly and Company, UCB S.A., LEO Pharma A/S, Almirall S.A., AstraZeneca plc, Bayer AG, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., AnaptysBio Inc., Acelyrin Inc., Arcutis Biotherapeutics Inc., Priovant Therapeutics, Aristea Therapeutics, Union Therapeutics, Revance Therapeutics

Read the full hidradenitis suppurativa market report here:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Hidradenitis Suppurativa Market?

North America was the largest region in the hidradenitis suppurativa market in 2025. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hidradenitis Suppurativa Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12599&type=smp

Browse Through More Reports Similar to the Global Hidradenitis Suppurativa Market 2026, By The Business Research Company

Dermatitis Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Seborrheic Dermatitis Global Market Report

https://www.thebusinessresearchcompany.com/report/seborrheic-dermatitis-global-market-report

Chronic Spontaneous Urticaria Global Market Report

https://www.thebusinessresearchcompany.com/report/chronic-spontaneous-urticaria-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795